Home » Topics » Regulatory

Regulatory
RSS

Fujisawa initiates enrollment in phase III RA trial of Prograf

July 27, 1999

OraSolv Zomig receives first regulatory approval in Sweden for migraine

July 22, 1999

Tachykinin antagonists now proposed for attention deficit disorders

July 22, 1999

Use of zonisamide for neurodegenerative disorders

July 21, 1999

Priority review status granted to Immunex's MS drug

July 21, 1999

PDT with Photofrin cleared in Canada for certain forms of lung cancer

July 19, 1999

FDA clears pioglitazone for type II diabetes

July 19, 1999

New label sought for Enbrel in early, active RA

July 16, 1999

Hoechst Marion Roussel files for new indication of Refludan in U.S. and E.U.

July 15, 1999

Nastech completes phase III testing of intranasal scopolamine

July 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...